Hypertension Background information for medical media outside the US only This selection gives an overview on background material for Hypertension available on the Boehringer Ingelheim corporate website.

Press Releases

• 18 June 2008Micardis®-based regimens help more patients achieve their blood pressure goals
• 14 April 2008New powerful antihypertensive MicardisPlus® 80/25 (80mg telmisartan/25mg hydrochlorothiazide) approved by EU Commission
• 18 June 2007More than half of hypertensive patients remain uncontrolled and thus at higher risk of heart attack and stroke - telmisartan may decrease this risk.
• 18 June 2007New study shows that telmisartan has greater renoprotective potential than losartan in hypertensive patients with type 2 diabetes
• press release archive

Documents

• Annual Report 2007: Page 56 - PDF (4.9 MB)

Related Links

• Focus on Clincal Research - interactive animation
• Landmark study: ONTARGET®
• Research & Development

External Links

• Boehringer Ingelheim Global Clinical Trials website
• The ONTARGET® clinical trial website